In-stent Neoatherosclerosis: a New Problem or an Opportunity to Rethink the Treatment of Coronary Disease?

Overview

Journal AsiaIntervention

Date 2024 Sep 30

PMID 39347113

Authors

Gian Paolo Ussia

Nino Cocco

Affiliations

Soon will be listed here.

References

Thrane P, Olesen K, Thim T, Gyldenkerne C, Mortensen M, Kristensen S . Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2023; 82(10):999-1010. DOI: 10.1016/j.jacc.2023.06.025. View

Madhavan M, Kirtane A, Redfors B, Genereux P, Ben-Yehuda O, Palmerini T . Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2020; 75(6):590-604. DOI: 10.1016/j.jacc.2019.11.058. View

Yamamoto F, Natsuaki M, Kuramitsu S, Ohya M, Otake H, Horie K . Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome. JACC Cardiovasc Interv. 2021; 14(10):1082-1090. DOI: 10.1016/j.jcin.2021.03.051. View

Lazar F, Onea H, Olinic D, Cortese B . A 2024 scientific update on the clinical performance of drug-coated balloons. AsiaIntervention. 2024; 10(1):15-25. PMC: 10900242. DOI: 10.4244/AIJ-D-23-00010. View

Camacho X, Nedkoff L, Wright F, Nghiem N, Buajitti E, Goldacre R . Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries. Lancet Public Health. 2022; 7(3):e229-e239. DOI: 10.1016/S2468-2667(22)00006-8. View

Stettler R, Dijkstra J, Raber L, Torii R, Zhang Y, Karanasos A . Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study. EuroIntervention. 2017; 13(15):e1831-e1840. DOI: 10.4244/EIJ-D-17-00051. View

Borovac J, DAmario D, Vergallo R, Porto I, Bisignani A, Galli M . Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother. 2018; 5(2):105-116. DOI: 10.1093/ehjcvp/pvy036. View

Steen D, Khan I, Andrade K, Koumas A, Giugliano R . Event Rates and Risk Factors for Recurrent Cardiovascular Events and Mortality in a Contemporary Post Acute Coronary Syndrome Population Representing 239 234 Patients During 2005 to 2018 in the United States. J Am Heart Assoc. 2022; 11(9):e022198. PMC: 9238606. DOI: 10.1161/JAHA.121.022198. View

Yang X, Yang Y, Guo J, Meng Y, Li M, Yang P . Targeting the epigenome in in-stent restenosis: from mechanisms to therapy. Mol Ther Nucleic Acids. 2021; 23:1136-1160. PMC: 7896131. DOI: 10.1016/j.omtn.2021.01.024. View

10.

Laforgia P, Auguadro C, Bronzato S, Durante A . The Reduction of Mortality in Acute Myocardial Infarction: From Bed Rest to Future Directions. Int J Prev Med. 2022; 13:56. PMC: 9188873. DOI: 10.4103/ijpvm.IJPVM_122_20. View